PRINCETON, N.J., March 25, 2011 /PRNewswire/ — CoreLab Partners, Inc,
the global entity resulting from the merger between RadPharm, Inc
and Medifacts International, is set to attend and actively
participate in several upcoming industry events around the world
over the next two weeks.
“The legacy of our organization has been the proactive insight
and collaborative input our physicians, scientists and operational
personnel have provided to the many industry associations,
professional healthcare organizations and
regulatory agencies around the world over the past decade,”
said CoreLab Partners’ Vice President of Global Business
Development, Kevin Duffy. “Many of our on-staff board-certified
radiologists, oncologists and cardiologists are recognized thought
leaders in their respective fields and continue to serve on many of
the industry-shaping advisory and steering committees in the drug
development market sector. This unwavering medical and scientific
commitment is a hallmark of CoreLab Partners expertise and signals
a corporate culture which is reflected in our new company tag line
for 2011: ‘Driven by Science,'” added Duffy.
CoreLab Partners invites you to learn more about their full line
of
cardiac safety and imaging science capabilities at these
important industry events: 28-30 March 201123rd Annual DIA Euro
MeetingGeneva, CHExhibiting: Booth # 1230
DIA Euro Meeting28-31 March 2011Drug Discovery World Asia/Drug
Safety World Asia 2011Marina Bay Sands, SingaporeExhibiting: booth
# A05Dr. Boaz Mendzelevski, VP, Cardiology, presenting, “Regulatory
trends in designing and analyzing QT studies to ensure drug
safety”Tuesday, 29th March, 14:00
‘/>”/>
SOURCE
